A new score to help predict survival when lung cancer spreads to the brain and spinal cord linings
Original title: Development and validation of a risk-stratification model for individualized management of leptomeningeal metastases in EGFR- mutant NSCLC (LM-Index).
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This came from looking back at records of real patients, and it is a planning tool, not a treatment.
The short version
Doctors built a simple score to help tell who is likely to do better or worse when EGFR-mutant lung cancer spreads to the linings of the brain and spinal cord.
What was studied. Researchers looked back at hospital records of people with EGFR-mutant non-small-cell lung cancer that had spread to the linings of the brain and spinal cord. They used 350 people to build the score, then tested it on a separate group of 302 people.
What they found. Five things were linked to shorter survival: being much less able to handle daily activities, cancer in the brain, certain changes on an MRI scan, cancer cells found in spinal fluid, and high pressure inside the head. The score sorted people into a lower-risk group and a higher-risk group. Survival time was 22.6 months in the lower-risk group and 9.9 months in the higher-risk group.
What this means, and what it doesn't
What it could mean: A score like this could help your care team explain what to expect in clearer terms. That can make it easier to plan ahead and to talk through treatment choices together.
What it doesn't mean: This is not a treatment and it is not a cure. It does not make anyone live longer by itself. The score came from looking back at past patient records, not from a trial that tested it in real time. It also does not predict what will happen to any one person. More testing is needed before a tool like this becomes a normal part of care.
Source: PubMed, July 21, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.